Thursday, November 22, 2018

Industry Calls for Changes to FDA’s DSCSA Product Identifier Guidance - RAPS.org

-----

-----

Read the full article:  Industry Calls for Changes to FDA’s DSCSA Product Identifier Guidance - RAPS.org

"The biggest change industry is calling for is for FDA to allow manufacturers to use the GS1 Global Trade Identification Number (GTIN), which typically contains the National Drug Code (NDC) number along with other information, in the human-readable portion of the product identifier in place of the NDC. This request is echoed by the Biotechnology Innovation Organization (BIO), the Association for Accessible Medicines, the Healthcare Distribution Alliance, Bristol-Myers Squibb, Shire and GS1 itself.

In its comments, the BIO also asks FDA to revise the guidance to allow manufacturers more flexibility when it comes to ordering the human-readable portion of the product identifier."

You might also be interested in:
ICYMI: FDA Released Three DSCSA-Related Guidances - Healthcare Packaging

Return Home:  The Designated Representative and Exemptee Blog

-------------

California Designated Representative Training Courses (wholesaler, 3PL, reverse distributor) - Approved by the California State Board of Pharmacy
California Designated Representative Training Courses (wholesaler, 3PL, reverse distributor) - Approved by the California State Board of Pharmacy

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

No comments:

Post a Comment

Custom Search

From SkillsPlus International Inc.